GNLX
GENELUX (GNLX)
NASDAQ
$3.01+$0.05 (+1.86%)
Price as of Jun 03, 2026 4:18 PM EDT
  • $136.8M
    Market Cap
  • 14.79%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
-47,000
-687.50%
8,000
-95.29%
170,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
-47,000
-687.50%
8,000
-95.29%
170,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-19.9M
+4.49%
-19.0M
+48.81%
-12.8M
N/A
Depreciation and Amortization Expense
244,000
+3.83%
235,000
-52.91%
499,000
N/A
Total Operating Expenses
33.2M
+4.79%
31.7M
+30.28%
24.3M
N/A
Operating Profit
-33.2M
+4.79%
-31.7M
+31.16%
-24.2M
N/A
Interest Income
711,000
+1.57%
700,000
+186.89%
244,000
N/A
Interest Expense
N/A
N/A
N/A
N/A
-36,000
N/A
Interest Income and Expense and Net
711,000
+1.57%
700,000
+236.54%
208,000
N/A
Total Nonoperating Income and Expense
1.1M
-41.49%
1.8M
+144.22%
-4.1M
N/A
Income before Taxes
-33.2M
+4.79%
-31.7M
+31.16%
-24.2M
N/A
Income Taxes
N/A
N/A
N/A
N/A
1.1M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-32.2M
+7.98%
-29.8M
+5.38%
-28.3M
N/A
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-28.3M
N/A
Basic EPS and Net Income
-0.86
-9.47%
-0.95
-18.10%
-1.16
N/A
Diluted EPS and Net Income
-0.86
-9.47%
-0.95
-18.10%
-1.16
N/A
Basic Weighted Average Shares
37.2M
+18.21%
31.5M
+28.74%
24.4M
N/A
Diluted Weighted Average Shares
37.2M
+18.21%
31.5M
+28.74%
24.4M
N/A
Balance Sheet
Cash and Cash Equivalents
5.3M
-37.73%
8.6M
-9.06%
9.4M
N/A
Short-Term Investments
N/A
N/A
22.3M
+62.13%
13.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
5.3M
-82.74%
30.9M
+33.22%
23.2M
N/A
Total Current Assets
15.1M
-52.04%
31.5M
+30.35%
24.2M
N/A
Accumulated Depreciation
3.9M
+6.60%
3.7M
+6.81%
3.4M
N/A
Property and Plant and Equipment and Net
2.2M
+64.89%
1.3M
+12.48%
1.2M
N/A
Total Long-Term Assets
144,000
-95.45%
3.2M
-14.15%
3.7M
N/A
Total Assets
19.0M
-45.19%
34.7M
+24.46%
27.9M
N/A
Income Taxes Payable
5.8M
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
900,000
+2,150.00%
40,000
N/A
Total Current Liabilities
6.2M
-9.82%
6.9M
+5.32%
6.6M
N/A
Total Long-Term Debt
N/A
N/A
16.5M
+25,295.38%
65,000
N/A
Total Long-Term Liabilities
1.3M
-18.26%
1.5M
-17.52%
1.9M
N/A
Total Liabilities
7.5M
-11.36%
8.4M
+0.26%
8.4M
N/A
Retained Earnings
-283.5M
+12.79%
-251.4M
+13.48%
-221.5M
N/A
Total Stockholders Equity
11.5M
N/A
N/A
N/A
19.5M
N/A
Total Shares Outstanding
38.1M
+9.82%
34.7M
+29.64%
26.8M
N/A
Cash Flow
Cash from Operating Activities
-25.3M
+19.03%
-21.2M
+4.70%
-20.3M
N/A
Capital Expenditures
1.1M
+188.19%
381,000
-62.83%
1.0M
N/A
Cash from Investing Activities
12.1M
+249.32%
-8.1M
-44.78%
-14.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.9M
-65.29%
28.5M
-35.24%
44.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
70,668.09%
+117.84%
-396,200.00%
N/A
N/A
N/A
Return on Assets
-119.83%
+25.80%
-95.25%
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
N/A
N/A
Revenue Growth
-687.50%
+621.45%
-95.29%
N/A
N/A
N/A
Current Ratio
2.43
-46.82%
4.57
N/A
N/A
N/A
Cash Ratio
0.86
-30.96%
1.24
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
0.50
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow